Review Articles
Vol. 4 No. 1 (2012): Reviews, Articles, Case Reports and Letters
https://doi.org/10.4084/mjhid.2012.045

PROPHYLAXIS OF MALARIA

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: June 29, 2012
20717
Views
1132
Downloads
17768
HTML
Malaria, Prevention, Prophylaxis
Infectious Diseases

Authors

Eli Schwartz
elischwa@post.tau.ac.il
low risk areas should be considered, Israel.
Malaria prevention in travelers to endemic areas remains dependent principally on chemoprophylaxis. Although malaria chemoprophylaxis refers to all malaria species, a distinction should be drawn between falciparum malaria prophylaxis and the prophylaxis of the relapsing malaria species (vivax & ovale). While the emergence of drug resistant strains, as well as the costs and adverse reactions to medications, complicate falciparum prophylaxis use,  there are virtually no drugs available for vivax prophylaxis, beside of  primaquine.
Based on travelers malaria data, a revised recommendation for using chemoprophylaxis in low risk areas  should be considered

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Ethics Approval

Review Articles
Eli Schwartz, low risk areas should be considered
Institute of Hematology, Catholic University, Director

How to Cite



“PROPHYLAXIS OF MALARIA” (2012) Mediterranean Journal of Hematology and Infectious Diseases, 4(1), p. e2012045. doi:10.4084/mjhid.2012.045.